The Valley Desk

Clinical trial reportJournal for immunotherapy of cancerPublished

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Penn Medicine, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Sarcoma; Carcinoma, Renal Cell; Soft Tissue Neoplasms; Salvage Therapy; Ipilimumab; Nivolumab; Immunotherapy; Kidney neoplasms; Clinical Trials, Phase Ii As Topic
PubMed ID
36948504
PubMed Central ID
PMC10040058
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal